Stigmasterol prevents glucolipotoxicity induced defects in glucose-stimulated insulin secretion.
about
Stigmasterol prevents glucolipotoxicity induced defects in glucose-stimulated insulin secretion.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Stigmasterol prevents glucolip ...... -stimulated insulin secretion.
@en
type
label
Stigmasterol prevents glucolip ...... -stimulated insulin secretion.
@en
prefLabel
Stigmasterol prevents glucolip ...... -stimulated insulin secretion.
@en
P2093
P2860
P1433
P1476
Stigmasterol prevents glucolip ...... e-stimulated insulin secretion
@en
P2093
Meliza G Ward
Valéria C Barbosa-Lorenzi
P2860
P2888
P356
10.1038/S41598-017-10209-0
P407
P50
P577
2017-08-25T00:00:00Z
P6179
1091298765